Revised RECIST guideline version 1.1: What oncologists want to know and what radiologists need to know.
OBJECTIVE
The objectives of this article are to review the new Response Evaluation Criteria in Solid Tumors (RECIST) guideline, version 1.1, highlighting the major changes in the new version compared with the original RECIST guideline (version 1.0), and to present case examples with representative imaging.


CONCLUSIONS
Familiarity with the revised RECIST is essential in day-to-day oncologic imaging practice to provide up-to-date service to oncologists and their patients. Some of the changes in the revised RECIST affect how radiologists select, measure, and report target lesions.
Nishino
Mizuki
M
Department of Imaging, Dana-Farber Cancer Institute, Boston, MA 02115, USA. Mizuki_Nishino@dfci.harvard.edu
Jagannathan
Jyothi P
JP
Ramaiya
Nikhil H
NH
Van den Abbeele
Annick D
AD
D003952:Diagnostic Imaging / Q000592:standards*; D019983:Guideline Adherence; D006801:Humans; D008495:Medical Oncology / Q000592:standards*; D009369:Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D017410:Practice Guidelines as Topic; D011871:Radiology / Q000592:standards*; D014481:United States